Search Results - "Panisset, M"

Refine Results
  1. 1

    The effect of COVID-19 lockdowns on exercise and the role of online exercise in Australians with multiple sclerosis by Panisset, MG, Galea, MP

    Published in Multiple sclerosis and related disorders (01-10-2023)
    “…•Melbourne, Australia experienced prolonged, repeated and strict lockdowns.•Effects on exercise in MS varied according to lockdown severity, disability and…”
    Get full text
    Journal Article
  2. 2

    REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia by VENDETTE, M, GAGNON, J.-F, DECARY, A, MASSICOTTE-MARQUEZ, J, POSTUMA, R. B, DOYON, J, PANISSET, M, MONTPLAISIR, J

    Published in Neurology (06-11-2007)
    “…To assess the relationship between the presence of REM sleep behavior disorder (RBD) and the cognitive profile of nondemented patients with Parkinson disease…”
    Get full text
    Journal Article
  3. 3

    Does early exercise attenuate muscle atrophy or bone loss after spinal cord injury? by Panisset, M G, Galea, M P, El-Ansary, D

    Published in Spinal cord (01-02-2016)
    “…Objectives: To systematically identify and assess the evidence on the efficacy of exercise initiated early after traumatic spinal cord injury (SCI). Methods: A…”
    Get full text
    Journal Article
  4. 4

    The Effect of the ENJOY Seniors Exercise Park Physical Activity Program on Falls in Older People in the Community: A Prospective Pre-Post Study Design by Levinger, Pazit, Dunn, J., Panisset, M. G., Haines, T., Dow, B., Batchelor, F., Biddle, S., Duque, G., Hill, K. D.

    Published in The Journal of nutrition, health & aging (01-03-2022)
    “…Background The ENJOY project (Exercise interveNtion outdoor proJect in the cOmmunitY for older people) is a community-based research project actively promoting…”
    Get full text
    Journal Article
  5. 5

    Implementing education: Personal communication with a healthcare professional is a critical step to address vaccine hesitancy for people with multiple sclerosis by Panisset, M.G., Kilpatrick, T., Cofré Lizama, L.E., Galea, M.P.

    Published in Multiple sclerosis and related disorders (01-07-2022)
    “…•In Australia, 15% of unvaccinated people with MS expressed hesitations, while 24% delayed uptake.•Unvaccinated people believed less in protection delivered by…”
    Get full text
    Journal Article
  6. 6

    REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease by GAGNON, J.-F, BEDARD, M.-A, FANTINI, M. L, PETIT, D, PANISSET, M, ROMPRE, S, CARRIER, J, MONTPLAISIR, J

    Published in Neurology (27-08-2002)
    “…To determine the frequency of REM sleep behavior disorder (RBD) among patients with PD using both history and polysomnography (PSG) recordings and to further…”
    Get full text
    Journal Article
  7. 7

    Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease by Moonen, A.J.H, Wijers, A, Leentjens, A.F.G, Christine, C.W, Factor, S.A, Juncos, J, Lyness, J.M, Marsh, L, Panisset, M, Pfeiffer, R, Rottenberg, D, Serrano Ramos, C, Shulman, L, Singer, C, Slevin, J, McDonald, W, Auinger, P, Richard, I.H

    Published in Parkinsonism & related disorders (01-06-2014)
    “…Abstract Background Antidepressants have appeared to be more effective than placebo treatment in treating depressive syndromes in patients with Parkinson's…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Neurobehavioral functioning after cessation of manganese exposure: A follow-up after 14 years by Bouchard, M., Mergler, D., Baldwin, M., Panisset, M., Bowler, R., Roels, H.A.

    Published in American journal of industrial medicine (01-11-2007)
    “…Background Little is known on the long‐term course of early manganese (Mn) neurotoxic effects. Mn alloy workers were examined in a follow‐up study 14 years…”
    Get full text
    Journal Article
  10. 10

    Neural substrates of cognitive skill learning in Parkinson’s disease by Beauchamp, M.H., Dagher, A., Panisset, M., Doyon, J.

    Published in Brain and cognition (01-11-2008)
    “…While cognitive skill learning is normally acquired implicitly through frontostrial circuitry in healthy individuals, neuroimaging studies suggest that…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent by PANISSET, M, GAUTHIER, S, MOESSLER, H, WINDISCH, M

    Published in Journal of Neural Transmission (01-07-2002)
    “…Cerebrolysin (Cere) is a compound with neurotrophic activity. It has been shown to be effective in the treatment of Alzheimer's disease (AD) in earlier trials…”
    Get full text
    Journal Article
  13. 13

    Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia by GAGNON, J.-F, FANTINI, M. L, BEDARD, M.-A, PETIT, D, CARRIER, J, ROMPRE, S, DECARY, A, PANISSET, M, MONTPLAISIR, J

    Published in Neurology (10-02-2004)
    “…To compare nondemented patients with Parkinson's disease (PD) with and without REM sleep behavior disorder (RBD) to healthy controls on quantitative EEG…”
    Get full text
    Journal Article
  14. 14

    Manganese neurotoxicity, a continuum of dysfunction: results from a community based study by Mergler, D, Baldwin, M, Bélanger, S, Larribe, F, Beuter, A, Bowler, R, Panisset, M, Edwards, R, de Geoffroy, A, Sassine, M P, Hudnell, K

    Published in Neurotoxicology (Park Forest South) (01-04-1999)
    “…Excessive manganese (Mn) has been associated with neurobehavioral deficits and neurological and/or neuropsychiatric illness, but the level at which this metal…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Naturalistic evaluation of entacapone in patients with signs and symptoms of L-dopa wearing-off by Jog, M., Panisset, M., Suchowersky, O., Réhel, B., Schecter, R.

    Published in Current medical research and opinion (01-11-2008)
    “…ABSTRACT Objective: To evaluate the effectiveness of entacapone in the management of levodopa wearing-off in Parkinson's disease (PD) in a naturalistic,…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    LRRK2 screening in a Canadian Parkinson's disease cohort by Grimes, D A, Racacho, L, Han, F, Panisset, M, Bulman, D E

    Published in Canadian journal of neurological sciences (01-08-2007)
    “…Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have become the most common known cause for developing Parkinson's disease. The frequency of…”
    Get more information
    Journal Article
  20. 20